Clinical significance of serum human papillomavirus DNA in cervical carcinoma

Obstetrics and Gynecology

Volumn 102, Issue 6, 2003, Pages 1344-1351

  Hsu, Keng Fu ^b   Huang, Soon Cen ^b   Hsiao, Jenn Ren ^b   Cheng, Ya Min ^b   Wang, Saprina P H ^b   Chou, Cheng Yang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; SQUAMOUS CELL CARCINOMA ANTIGEN; VIRUS DNA;

ADENOCARCINOMA; ADULT; ARTICLE; BENIGN TUMOR; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARAMETRIC TEST; PATHOPHYSIOLOGY; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0345118235     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.obstetgynecol.2003.08.023     Document Type: Article

References (30)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of worldwide incidence of 25 major cancers in 1990. Int J Cancer. 80:1999;827-841.
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al. Prevalence of human papillomavirus in cervical cancer A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study group . J Natl Cancer Inst. 87:1995;796-802.
3. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505.
4. Jones D.L., Munger K. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol. 71:1997;2905-2912.
5. Zur Hausen H. Papillomaviruses causing cancer Evasion from host-cell control in early events in carcinogenesis . J Natl Cancer Inst. 92:2000;690-698.
6. Duensing S., Duensing A., Flores E.R., Do A., Lambert P.F., Munger K. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J Virol. 75:2001;7712-7716.
7. Chen T.M., Chen C.A., Wu C.C., Huang S.C., Chang C.F., Hsieh C.Y. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int J Cancer. 57:1994;181-184.
8. Mutirangura A., Pornthanakasem W., Theamboonlers A., Sriuranpong V., Lertsanguansinchi P., Yenrudi S., et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res. 4:1998;665-669.
9. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 59:1999;1188-1191.
10. Pao C., Hor J., Yang F., Lin C., Tseng C. Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol. l15:1997;1008-1012.
11. Mutirangura A. Serum/plasma viral DNA Mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma . Ann N Y Acad Sci. 945:2001;59-67.
12. Chou C.Y., Hsu K.F., Wang S.T., Huang S.C., Tzeng C.C., Huang K.E. Accuracy of three-dimensional ultrasonography in volume estimation of cervical carcinoma. Gynecol Oncol. 66:1997;89-93.
13. Chou C.Y., Wang S.T., Kuo H.C., Tzeng C.C., Yao B.L. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer. Cancer. 74:1994;2497-2501.
14. Hsiao J.R., Jin Y.T., Tsai S.T. Detection of cell-free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer. 94:2002;723-729.
15. Chou C.Y., Shen M.R., Wu S.N. Volume-sensitive chloride channels associated with human cervical carcinogenesis. Cancer Res. 55:1995;6077-6083.
16. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 92:2000;709-720.
17. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shan K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:1999;12-19.
18. Fugua S.A.W., Falette N.F., McGuire W.L. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst. 82:1990;858-861.
19. Chou C.Y., Chen Y.H., Tzeng C.C., Cheng Y.C., Chang C.F., Chen T.M. Establishment and characterization of a human-papillomavirus negative, p53-mutant negative human cervical cancer cell line. Cancer Lett. 102:1996;173-181.
20. Anker P., Mulcahy H., Chen X.Q., Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 18:1999;65-73.
21. Silva J.M., Dominguez G., Garcia J.M., Gonzalez R., Villanueva M.J., Navarro F., et al. Presence of tumor DNA in plasma of breast cancer patients Clinicopathological correlations . Cancer Res. 59:1999;3251-3256.
22. Sozzi G., Conte D., Mariani L., Vullo S.L., Roz L., Lombardo C., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61:2001;4675-4678.
23. Lo Y.M., Chan A.T., Chan L.Y., Leung S.F., Lam C.W., Huang D.P., et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res. 60:2000;6878-6881.
24. Capone R.B., Pai S.I., Koch W.M., Gillison M.L., Danish H.N., Westra W.H., et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 6:2000;4171-4175.
25. Garcia-Olmo D., Garcia-Olmo D.C., Ontanon J., Martinez E. Horizontal transfer of DNA and the "genometastasis hypothesis" Blood. 15:2000;724-725.
26. Liu V.W.S., Tsang P., Yip A., Ng T.Y., Wong L.C., Ngan H.Y.S. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol. 82:2001;269-272.
27. Tseng C.J., Pao C.C., Lin J.D., Soong Y.K., Hong J.H., Hsueh S. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol. 17:1999;1391-1396.
28. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 40:1977;1621-1628.
29. Duk J.M., Groenier K.H., de Bruijn H.W., Hollema H., ten Hoor K.A., van der Zee A.G., et al. Pretreatment serum squamous cell carcinoma antigen A newly identified prognostic factor in early-stage cervical carcinoma . J Clin Oncol. 14:1996;111-118.
30. Bolli J.A., Doering D.L., Bosscher J.R., Day T.G., Rao C.V., Owens K., et al. Squamous cell carcinoma antigen Clinical utility in squamous cell carcinoma of the uterine cervix . Gynecol Oncol. 55:1994;169-173.